勤劳
发表于 2025-3-25 03:33:44
978-1-4939-8406-0Springer Science+Business Media LLC 2017
Invigorate
发表于 2025-3-25 11:16:45
Nonclinical Development of Combination Drugsbination a detailed review of the nonclinical data available may suffice, particularly when the components have a history of coadministration at about the same dose and ratio as that of the proposed combination. For a marketed drug/NME combination, in addition to a review of the data for the markete
诱骗
发表于 2025-3-25 15:27:14
Applications of Mass Spectrometry Imaging for Safety Evaluationvelopment phases. MSI allows to potentially address important questions in drug development such as “What is the localization of the drug and its metabolites in the tissues?”, “What is the pharmacological effect of the drug in this particular region of interest?”, or “Is the drug and its metabolites
Melanocytes
发表于 2025-3-25 18:22:44
In Vivo Rat T-Lymphocyte , Assay: Detection and Expansion of Cells Deficient in the GPI-Anchored CD4nds of interest. Our methodology of combining phenotypic antibody labeling, magnetic enrichment, sorting, and single-cell clonal expansion can be used in genotoxicity/mutagenicity studies and in other general immunotoxicology research requiring identification, isolation, and expansion of extremely r
Herbivorous
发表于 2025-3-25 20:55:13
http://reply.papertrans.cn/29/2832/283125/283125_25.png
helper-T-cells
发表于 2025-3-26 03:32:52
NMR and MS Methods for Metabolomics drug development and molecular medicine are described in great detail, starting from sample preparation to determining the measurement details of all analytical platforms, and finally to discussing the corresponding specific steps of data analysis.
匍匐前进
发表于 2025-3-26 07:59:05
http://reply.papertrans.cn/29/2832/283125/283125_27.png
pacific
发表于 2025-3-26 11:06:16
Changing composition of paid workforcesbination a detailed review of the nonclinical data available may suffice, particularly when the components have a history of coadministration at about the same dose and ratio as that of the proposed combination. For a marketed drug/NME combination, in addition to a review of the data for the markete
发炎
发表于 2025-3-26 15:28:15
Practices and Orientations of CSCLvelopment phases. MSI allows to potentially address important questions in drug development such as “What is the localization of the drug and its metabolites in the tissues?”, “What is the pharmacological effect of the drug in this particular region of interest?”, or “Is the drug and its metabolites
Ruptured-Disk
发表于 2025-3-26 17:07:16
Designing Sociable CSCL Environmentsnds of interest. Our methodology of combining phenotypic antibody labeling, magnetic enrichment, sorting, and single-cell clonal expansion can be used in genotoxicity/mutagenicity studies and in other general immunotoxicology research requiring identification, isolation, and expansion of extremely r